• Mashup Score: 0
    Expanded Access to VAL-083 :: Val-083 Clinical Trials - 1 year(s) ago

    Requests for Expanded Access to Investigational (Unapproved) Drugs This Policy for Requests for Expanded Access to Investigational Drugs describes the principles and procedures that Kintara Therapeutics, Inc. (“Kintara” or “the Company”) will follow when considering requests by licensed physicians for use of Kintara’s investigational drugs outside of clinical trials in accordance with the…

    Source: Val-083 Clinical Trials
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      Expanded Access programs can provide experimental but potentially life-saving treatments to patients facing serious illness. Thank you to @Kintara_Thera for offering VAL-083 treatment to advanced glioblastoma patients. I’m proud to offer this at Yale https://t.co/9L0y5oFWdD

  • Mashup Score: 2
    Neuro-onc Questionnaire Validation - 1 year(s) ago

    Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…

    Source: redcap.uth.tmc.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      Neuro-oncologists, we need your help with a brief 8 question survey on your thoughts about neuro-oncology education. Please click the link and help improve neuro-onc education! https://t.co/D6f7VcE3Ok @NeuroOnc @ASCO @NBTStweets

  • Mashup Score: 0
    The Mechanisms of Action of Tumor Treating Fields - PubMed - 2 year(s) ago

    Tumor treating fields (TTFields), a new modality of cancer treatment, are electric fields transmitted transdermally to tumors. The FDA has approved TTFields for the treatment of glioblastoma multiforme and mesothelioma, and they are currently under study in many other cancer types. While antimitotic …

    Source: PubMed
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      TTFields is an anti-mitotic therapy and mechanisms of action have been published in high level journals- Cancer Research 2022 - https://t.co/ja2Zve0YM0 If a person “doesn’t really believe that it works” then they are not aware of the actual data https://t.co/skhENIjOTe

  • Mashup Score: 1
    Highly sensitive EGFRvIII detection in circulating extracellular vesicle RNA of glioma patients - 2 year(s) ago

    Abstract. Purpose: Liquid biopsy offers an attractive platform for non-invasive tumor diagnosis, prognostication and prediction of glioblastoma clinical outcomes. Prior studies report that 30-50% of GBM lesions characterized by EGFR amplification also harbor the EGFRvIII mutation. Experimental Design: A novel digital droplet PCR (ddPCR) assay for high GC content amplicons was developed and…

    Source: American Association for Cancer Research
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      We are finally closing in on blood tests to monitor glioblastoma activity and progression. I truly hope this will become commercially available within the next few years. It will be a game changer in GBM treatment #DefeatGBM https://t.co/lIvU1K3Nwz

  • Mashup Score: 0
    Support Nicholas Blondin - Swim Across the Sound - 2 year(s) ago

    We’re so excited to be swimming in the 2022 Swim Across the Sound! This organization’s mission is very important to us and we’re proud to help them make a difference. Please join us in supporting cancer patients in the Fairfield Region by making a donation today. Large or small, all contributions are greatly appreciated. Thank you.

    Source: PledgeIt for Charities
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      (2/2) The donations to the Swim Across The Sound directly provide financial help to my patients undergoing treatment for brain cancer. We have a wonderful navigator Kim at Smilow Trumbull who helps facilitate this for my patients. Any amount is appreciated https://t.co/83xwlvPYTt

  • Mashup Score: 0
    Congress Introduces the Childhood Cancer STAR Reauthorization Act! — Children's Cancer Cause - 2 year(s) ago

    We are thrilled to report that the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Reauthorization Act has been officially introduced in both chambers of Congress! The original Childhood Cancer STAR Act was signed into law in 2018 and authorized five years of funding at $30 m

    Source: Children's Cancer Cause
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      Childhood cancer research can’t be put on hold. @jahimes @senmurphyoffice @SenBlumenthal, please support the Childhood Cancer STAR Reauthorization Act to continue the progress in developing cures and improving quality of life for pediatric cancer patients https://t.co/xGrrBbPRJ7

  • Mashup Score: 4
    Support Nicholas Blondin - Swim Across the Sound - 2 year(s) ago

    We’re so excited to be swimming in the 2022 Swim Across the Sound! This organization’s mission is very important to us and we’re proud to help them make a difference. Please join us in supporting cancer patients in the Fairfield Region by making a donation today. Large or small, all contributions are greatly appreciated. Thank you.

    Source: PledgeIt for Charities
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicholasBlondin
      NicholasBlondin

      @Dr_AmerZeidan I’ll be swimming 17 miles across Long Island Sound with my team on August 6! https://t.co/83xwlvPYTt

Load More